These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20824430)

  • 61. Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas.
    Akporiaye ET; Bradley-Dunlop D; Gendler SJ; Mukherjee P; Madsen CS; Hahn T; Besselsen DG; Dial SM; Cui H; Trevor K
    Vaccine; 2007 Sep; 25(39-40):6965-74. PubMed ID: 17707958
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
    Wu HY; Russell MW
    Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates.
    Johansson EL; Rask C; Fredriksson M; Eriksson K; Czerkinsky C; Holmgren J
    Infect Immun; 1998 Feb; 66(2):514-20. PubMed ID: 9453604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
    Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
    J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine.
    Lee A; Chen M
    Infect Immun; 1994 Aug; 62(8):3594-7. PubMed ID: 8039937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.
    George-Chandy A; Eriksson K; Lebens M; Nordström I; Schön E; Holmgren J
    Infect Immun; 2001 Sep; 69(9):5716-25. PubMed ID: 11500448
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice.
    Dong H; Huang Y; Yao S; Liang B; Long Y; Xie Y; Mai J; Gong S; Zhou Z
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5819-5829. PubMed ID: 28608279
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
    Katz J; Harmon CC; Buckner GP; Richardson GJ; Russell MW; Michalek SM
    Infect Immun; 1993 May; 61(5):1964-71. PubMed ID: 8478086
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice.
    Wu X; Yin Z; McKay C; Pett C; Yu J; Schorlemer M; Gohl T; Sungsuwan S; Ramadan S; Baniel C; Allmon A; Das R; Westerlind U; Finn MG; Huang X
    J Am Chem Soc; 2018 Dec; 140(48):16596-16609. PubMed ID: 30398345
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
    Eriksson K; Fredriksson M; Nordström I; Holmgren J
    Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity.
    Jie J; Zhang Y; Zhou H; Zhai X; Zhang N; Yuan H; Ni W; Tai G
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558459
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.
    Chen D; Xia J; Tanaka Y; Chen H; Koido S; Wernet O; Mukherjee P; Gendler SJ; Kufe D; Gong J
    Immunology; 2003 Jun; 109(2):300-7. PubMed ID: 12757626
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model.
    Karimi Bavandpour A; Bakhshi B; Najar-Peerayeh S
    Int J Pharm; 2020 Jan; 573():118868. PubMed ID: 31765785
    [TBL] [Abstract][Full Text] [Related]  

  • 78. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides.
    Wang Y; Krieg AM
    Vaccine; 2004 Jun; 22(20):2641-50. PubMed ID: 15193390
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine.
    Samuel J; Budzynski WA; Reddish MA; Ding L; Zimmermann GL; Krantz MJ; Koganty RR; Longenecker BM
    Int J Cancer; 1998 Jan; 75(2):295-302. PubMed ID: 9462722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.